Medican Enterprises, Inc. (MDCN)
OTC
Healthcare
Medical - Pharmaceuticals
$0.00
▲ +0.00%
Market Cap
$2.9M
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Beta
-3.96
52-Wk Range
0.0001-0.0001
CEO
Mitchell Xavier
Country
US
Currency
USD
Medican Enterprises, Inc. operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Los Angeles, CA, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $2.9M. On trailing twelve-month figures it carries a trailing P/E of -3.38, a net margin of 0.0%. Its beta of -3.96 implies it has historically moved less than the broad market.
Valuation & profitability (TTM)
P/E
-3.38
Price / Sales
0.00
Price / Book
0.14
EV / EBITDA
-18.70
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
—
Debt / equity
0.70
Current ratio
0.00
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
3
IPO date
1995-02-21
Headquarters
Los Angeles, CA, US
About Medican Enterprises, Inc.
Medican Enterprises, Inc. is a bio-pharmaceutical company, which engages in the production, cultivation, and wholesale distribution of cannabis related products. The company was founded on October 27, 1988 and is headquartered in Los Angeles, CA.
Comparable companies
Medican Enterprises, Inc. is most often compared with the following Healthcare names:
More research on MDCN
Open full interactive analysis & DCF →